Navigation Links
Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery

ration of action, and accumulates over time in the body, it is rarely used to control BP during surgery, and is only used occasionally after surgery.

About Cleviprex

Cleviprex is a novel, investigational drug rationally designed to meet the needs of the acute care practitioner for an intravenous hypertensive agent. It is the first third-generation dihydropyridine calcium channel blocker that acts rapidly and reliably, is vascular- and arterial- selective, and has an ultrashort half-life. Cleviprex recently completed Phase III clinical trials.

MDCO-G

About The Medicines Company

The Medicines Company is committed to delivering innovative, cost- effective acute care products in the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the U.S. and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Company also has two products in late-stage development, Cleviprex(TM) (clevidipine) and cangrelor. The Company's website is http://www.themedicinescompany.com.

Statements contained in this press release about The Medicines Company and Cleviprex that are not purely historical, and all other statements that are not purely historical, may be deemed to be forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "believes," "anticipates" and "expects" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Important factors that may cause or contribute
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
10. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
11. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
Post Your Comments:
(Date:10/6/2008)...proved Pharmacokinetic Characteristics of Naltrexo...bility in Clinical Trials -, PHOENIX, Oct. 6 /PRN...(Nasdaq: OREX ), a biopharmaceutical company focu...nervous system-related disorders, today presented,... (naltrexone SR /,bupropion SR), successfully achi...
(Date:10/6/2008)...SEATTLE, Oct. 6 /- Dendreon... call today, Monday, October 6, 2008 at 9:00 AM,ET... analysis of its IMPACT,(IMmunotherapy for Prostat...clinical trial of PROVENGE(R) (sipuleucel-T), the ...erapy for the treatment of advanced prostate,cance...
(Date:10/6/2008)...Recent study revealed that drinking polyphenol-ric... changes in appetite, energy intake or body,weight...consumption of 100%,polyphenol-rich Concord grape ...ot associated with changes in appetite and was sho...data presented at the 49th Annual Meeting of,the A...
(Date:10/3/2008)...Burlington County, New Jersey is the newest study .../ -- The Children,s Hospital,of Philadelphia today... The,National Children,s Study. Children,s Hospita... data collection in Burlington County, New,Jersey.... Health., Investigators anticipate approximately ...
Breaking Medicine Technology:Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2FDA Demands Tougher Warnings on Immunosuppressive Drugs 26079 1FDA Demands Tougher Warnings on Immunosuppressive Drugs 26079 2FDA Demands Tougher Warnings on Immunosuppressive Drugs 26079 3Schofield Publishing Enters the Newsletter Market 26074 1Schofield Publishing Enters the Newsletter Market 26074 2VIDEO from Medialink and Kelloggs 3A Its All in the Jeans 26068 1Study 3A Delaying evolution of drug resistance in malaria parasite possible 26064 1Study 3A Delaying evolution of drug resistance in malaria parasite possible 26064 2Study 3A Delaying evolution of drug resistance in malaria parasite possible 26064 3
...WIRE)--Jul 3, 2007 - EPIX,Pharmaceuticals, Inc. (N...an, M.D., Ph.D., chief executive officer of EPIX, ...bin Emerging Growth,Opportunities Conference on Tu...darin Oriental Hotel in New York, NY., The present...the,EPIX website, www.epixpharma.com, in the inves...
...Jul 2, 2007 - Metabasis Therapeutics,(NASDAQ:MBRX)...very, development and commercialization of novel d...ases by targeting the liver,and liver pathways, an...t of finance and chief financial officer of Metaba...rging Growth Opportunities,Conference at the Manda...
Other Medicine Technology:EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth,Conference and Attend Pacific Growth Equities Conference 2
(Date:10/6/2008)...S, Ohio, Oct. 6 /PRNewswire/ -- Ohio,s academic he...e state,s economy in 2007, an,increase of approxim...jor,job generator, employing one in 12 Ohioans, ac... Council of Medical Deans., Quantifying academic ...ax revenue to job creation, the report underscores...
(Date:10/6/2008)... Millions of women suffer with sympt...-billion economic rescue plan. But the effects of ... to come making it increasingly difficult for U.S....tricia Beckstead announces new cost effective drug...f without a prescription. , ...
(Date:10/6/2008)...F, Germany, Oct. 6 /PRNewswire-FirstCall/ -- SAP A...a has joined SAP as senior vice president,of the H..., effective,August 1, 2008, Mr. Papandrea will hel...ding strategic software solutions to healthcare,or... made in conjunction,with the 3rd annual Ambassado...
(Date:10/5/2008)...A--A simple blood test may help detect serious bac...ions and blood stream infections in young infants ...ers that have no clear cause. Researchers at Child...ators at George Washington University, show that a...lp identify infants at high risk for SBIs while po...
Breaking Medicine News(10 mins):Health News:Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2
... fractures linked to osteoporosis without the need...ifornia have been looking at the effect of a new t...ients with osteoporosis. They injected an acrylic ...rly done during surgery. Two weeks later//, many p...
...ly detection of all forms of cancer has been devel...lesterol test, the 'C-Test' will be evaluated in a...hs. It is based on scientific work by the John Bas...t the Engalnd National University. Professor Rodri...
... of the potentially fatal condition pre-eclampsia ...The study, published in the Lancet, found that tak...g pre-eclampsia. The condition involves the pregn...can interfere with the feeding of the unborn child...
...echnology will provide the most effective defence ...genome project, and developments in understanding...in developing tests and vaccines that will protect...- as well as natural epidemics.// The annual meeti...
Other Medicine News:Health News:Detection of Cancer 2Health News:Biotechnology on the lead 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: